03/31/2023

Christopher Cowles featured in Life Sciences IP Review

The article discusses the recent, highly anticipated US Supreme Court hearings between Amgen and Sanofi, two pharmaceutical companies, regarding the true definition and test of “enablement” under Section 112 of the US Patent Act.